3 articles found

GPH Journal of Medical SciencesMay 17, 2026

Efficacy and Durability of High-Frequency Repetitive Transcranial Magnetic Stimulation Targeting the Left Dorsolateral Prefrontal Cortex in Treatment-Resistant Major Depressive Disorder: A Randomized, Sham-Controlled Trial with 6-Month Follow-Up

Importance: Treatment-resistant major depressive disorder (TRD) affects approximately one-third of patients with MDD and is associated with profound functional disability and excess mortality. High-frequency rTMS has regulatory approval for MDD but i...

treatment-resistant depressionrepetitive transcranial magnetic stimulationDLPFCneuromodulationrandomized controlled trial

Read Article →DOI

GPH Journal of Medical SciencesMay 10, 2026

Glycemic Efficacy and Metabolic Outcomes of Dual GLP-1/GIP Receptor Agonist Therapy in Adults with Inadequately Controlled Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

Background12345: Dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonism represents a mechanistically promising approach to improving glycemic control in type 2 diabetes mellitus (T2DM). Prior evi...

GIP receptor agonistGLP-1 receptor agonistHbA1cdual incretinrandomized controlled trial

Read Article →DOI

GPH Journal of Medical SciencesMar 18, 2026

Impact of Artificial Intelligence on Early Detection of Cardiovascular Diseases: A Systematic Review and Meta-Analysis : Updated

Background: Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, accounting for approximately 17.9 million deaths annually. Early detection through artificial intelligence (AI) has shown promise in improving diagnostic accu...

PRISMAartificial intelligencecardiovascular diseasedeep learningdiagnostic accuracy

Read Article →DOI